ENTA NASDAQ
Enanta Pharmaceuticals, Inc.
1W: +9.1%
1M: -8.0%
3M: -10.7%
YTD: -10.1%
1Y: +22.1%
3Y: +12.7%
5Y: -76.9%
$12.96
+0.12 (+0.93%)
Weekly Expected Move ±7.0%
$11
$12
$13
$14
$15
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$65M
Revenue
+0.7% YoY
$-63M
Net Income
+31.3% YoY
$-37M
Free Cash Flow
+15.2% YoY
100.0%
Gross Margin
-120.0%
Op. Margin
-135.8%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-70.1%
ROA-21.2%
ROIC141.5%
Valuation
P/E-5.4
P/B3.7
EV/EBITDA-6.2
Leverage
Debt/Equity0.55
Current Ratio3.76
Interest Cov.-3.9x
Quality Scores
Piotroski F4/9
Altman Z-0.55
Beneish M-0.54